Rite Aid Corporation (NYSE:RAD) today announced sales results for June.
Monthly Sales
For the four weeks ended June 27, 2009, same store sales decreased 0.6
percent over the prior year period. June front-end same store sales
decreased 4.5 percent while pharmacy same store sales, which included an
approximate 484 basis points negative impact from new generic
introductions, increased 1.4 percent.
For the four weeks ended June 27, 2009, same store sales excluding the
acquired Brooks Eckerd stores were flat compared to the prior-year
period with front-end same store sales decreasing 4.4 percent and
pharmacy same store sales increasing 2.6 percent.
For the four weeks ended June 27, 2009, same store sales at the acquired
Brooks Eckerd stores declined 1.8 percent over the prior-year period
with front-end same store sales decreasing 5.0 percent and pharmacy same
store sales decreasing 0.7 percent.
Total drugstore sales for the four-week period decreased 2.5 percent to
$1.973 billion compared to $2.023 billion for the same period last year.
Prescription revenue accounted for 67.9 percent of drugstore sales, and
third party prescription revenue represented 96.3 percent of pharmacy
sales.
Year-to-Date Sales
Same store sales for the 17-week period ended June 27, 2009 increased
0.3 percent, consisting of a 2.3 percent decrease in front-end same
store sales and a 1.6 percent increase in pharmacy same store sales.
Total drugstore sales for the 17 weeks ended June 27, 2009 decreased 1.5
percent to $8.479 billion compared to $8.610 billion in last year’s like
period. Prescription revenue represented 68.1 percent of total drugstore
sales, and third party prescription revenue was 96.3 percent of pharmacy
sales.
Rite Aid is one of the nation’s largest drugstore chains. On June 27,
2009, the company operated 4,822 stores compared to 4,988 stores in the
like period a year ago. Information about Rite Aid, including corporate
background and press releases, is available through the company’s
website at http://www.riteaid.com.
Rite Aid Corporation
Investors:
Chris Hall, 717-214-8834
investor@riteaid.com
or
Media:
Karen
Rugen, 717-730-7766
